Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204

Personal Subscription
Become EABM
Become Reviewer

Spectrum of Radiopharmaceuticals in Nuclear Oncology

Volume:6   Issue: 3
Pp: 181-196
Delphine Denoyer, Nathalie Perek, Nathalie L. Jeune and Francis Dubois
DOI: 10.2174/156800906776842984

γ-H2AX as a Therapeutic Target for Improving the Efficacy of Radiation Therapy

Volume:6   Issue: 3
Pp: 197-205
J. Kao, M. T. Milano, A. Javaheri, M. C. Garofalo, S. J. Chmura, R. R. Weichselbaum and S. J. Kron
DOI: 10.2174/156800906776842957

Molecular Targets of Ovarian Carcinomas with Acquired Resistance to Platinum/Taxane Chemotherapy

Volume:6   Issue: 3
Pp: 207-227
Christian Kurzeder, Georg Sauer and Helmut Deissler
DOI: 10.2174/156800906776842975

Vitamin D Receptor is a Novel Drug Target for Ovarian Cancer Treatment

Volume:6   Issue: 3
Pp: 229-244
Xiaohui Zhang, Santo V. Nicosia and Wenlong Bai
DOI: 10.2174/156800906776842939

Specialisation of the Tropomyosin Composition of Actin Filaments Provides New Potential Targets for Chemotherapy

Volume:6   Issue: 3
Pp: 245-256
Justine R. Stehn, Galina Schevzov, Geraldine M. O'Neill and Peter W. Gunning
DOI: 10.2174/156800906776842948

Gonadotropin-Releasing Hormone (GnRH) Receptors in Tumors: a New Rationale for the Therapeutical Application of GnRH Analogs in Cancer Patients?

Volume:6   Issue: 3
Pp: 257-269
M. M. Marelli, R. M. Moretti, J. Januszkiewicz-Caulier, M. Motta and P. Limonta
DOI: 10.2174/156800906776842966